Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linking Surrogate Endpoints to Long-term Final Outcomes in MASLD/MASH: A Korean Multicentre Real-World Evidence Study

NCT07739901 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07739901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linking Surrogate Endpoints to Long-term Final Outcomes in MASLD/MASH: A Korean Multicentre Real-World Evidence Study
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Active, not recruiting
Start date
July 13, 2026
Completion date
September 30, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

masld/mash